Sulfonylureas in diabetes mellitus. 1958

G W SOBEL, and R LEVINE

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea

Related Publications

G W SOBEL, and R LEVINE
September 1983, Medicina clinica,
G W SOBEL, and R LEVINE
April 1960, El Dia medico,
G W SOBEL, and R LEVINE
July 1957, Annals of the New York Academy of Sciences,
G W SOBEL, and R LEVINE
January 1956, Diabetes,
G W SOBEL, and R LEVINE
January 1959, Hospital (Rio de Janeiro, Brazil),
G W SOBEL, and R LEVINE
July 1985, Mayo Clinic proceedings,
G W SOBEL, and R LEVINE
February 1958, Revista brasileira de medicina,
G W SOBEL, and R LEVINE
August 1958, Schweizerische medizinische Wochenschrift,
G W SOBEL, and R LEVINE
April 1959, Klinische Wochenschrift,
G W SOBEL, and R LEVINE
April 1956, Science (New York, N.Y.),
Copied contents to your clipboard!